Full Text View
Tabular View
No Study Results Posted
Related Studies
AMA1-C1/Alhydrogel + CpG 7909 for Malaria
This study has been completed.
Study NCT00344539   Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received on June 22, 2006.   Last Updated on April 4, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Plasmodium Falciparum Malaria
Additional conditions recognized in this trial
Malaria
Malaria, Falciparum
More general conditions related to this trial
Parasitic Diseases
Protozoan Infections
Interventions listed in this trial
AMA1-C1/Alhydrogel®
Additional drug interventions recognized in this trial
Aluminum Hydroxide
More general drug interventions related to this trial
Adjuvants, Immunologic
Antacids
Immunologic Factors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services